Skip to main content
Clinical Trials/NCT04857879
NCT04857879UnknownNot Applicable

A Pilot Randomized Controlled Trial to Assess the Implementation and Outcomes of Good Life With Osteoarthritis (GLA:D) Program in West Virginians Suffering From the Osteoarthritis of the Knee

Marshall University1 site in 1 country24 target enrollmentStarted: August 6, 2021Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
24
Locations
1
Primary Endpoint
Change in Knee injury and Osteoarthritis Outcome Score (KOOS4) scores from baseline to 12-weeks later

Study Overview

Brief Summary

This study will examine feasibility of implementing Good Life with Osteoarthritis in Denmark (GLA:D) program in West Virginians with osteoarthritis of the knee

Detailed Description

Using West Virginia (WV) as an implementation site, this study will examine the feasibility of process implementation and effectiveness of the Good Life with Osteoarthritis in Denmark (GLA:D) program in individuals with osteoarthritis of the knee (KOA). Specifically, the study will examine the feasibility and acceptability of the GLA:D program in individuals with KOA. This study will also assess the magnitude of changes in self-reported knee pain and functional impairments as well as physical performance in individuals who receive GLA:D compared to those who receive control interventions consisting of disease-specific education and exercises for KOA.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
45 Years to 90 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Between 45 to 90 years of age,
  • •Osteoarthritis of the knee (KOA) (Kellgren and Lawrence grade 2, 3, or 4) confirmed by an orthopedic surgeon based on plain film radiographs and symptoms, and
  • •Recommendation by an orthopedic surgeon to pursue conservative management of KOA.

Exclusion Criteria

  • •Prior joint replacement surgery in the ipsilateral knee,
  • •Known history of cognitive impairments or any neurodegenerative disease,
  • •Any other neurological or musculoskeletal pathologies that have resulted in permanent mobility deficits or functional impairments,
  • •Medical conditions that would preclude them from participating in exercise programs, and
  • •Inability to read and comprehend English.

Arms & Interventions

Good Life with Osteoarthritis (GLA:D) Program

Experimental

Participants will attend 2 sessions aimed at providing disease-specific education followed by 12 sessions of neuromuscular exercises, each 1 hour in length, delivered twice a week over 6 weeks.

Intervention: GLA:D program (Good Life with osteoArthritis in Denmark) (Other)

Control intervention group

Active Comparator

Participants allocated to the control intervention will receive disease-specific education and training to learn home exercises in a 1-hour group session. They will receive a booster session 4-weeks after the first session.

Intervention: GLA:D program (Good Life with osteoArthritis in Denmark) (Other)

Outcomes

Primary Outcomes

Change in Knee injury and Osteoarthritis Outcome Score (KOOS4) scores from baseline to 12-weeks later

Time Frame: 12-weeks

The KOOS4 is a variant of full length KOOS that has all subscales of full length KOOS (pain, symptoms, ADL, and QOL) except sports and recreation activities subscale. There are 9 items in the pain subscale, 7 items in the symptom subscale, 17 items in the ADL subscale, and 4 items in the QOL subscale. The items across these subscales are scored on the scale of 0 to 4 where 0 indicates no problem and 4 indicates an extreme problem. Each subscale has sufficient stability and dimensionality, and therefore the score for each subscale is calculated independently on 0-100 interval with 0 indicating an extreme problem and 100 indicating no problems.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Saurabh

Associate Professor, School of Physical Therapy

Marshall University

Study Sites (1)

Loading locations...

Similar Trials